CEL-SCI (NYSEAMERICAN:CVM) issued its quarterly earnings data on Monday. The company reported ($0.53) earnings per share (EPS) for the quarter, Bloomberg Earnings reports. The company had revenue of $0.11 million for the quarter.
CEL-SCI (NYSEAMERICAN:CVM) opened at $1.75 on Wednesday. The stock has a market cap of $21.77, a P/E ratio of -1.09 and a beta of -1.49. CEL-SCI has a 1-year low of $1.46 and a 1-year high of $4.00.
COPYRIGHT VIOLATION NOTICE: “CEL-SCI (CVM) Announces Quarterly Earnings Results” was first reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this article on another publication, it was illegally stolen and reposted in violation of United States and international trademark & copyright laws. The legal version of this article can be read at https://www.dispatchtribunal.com/2018/02/14/cel-sci-cvm-announces-quarterly-earnings-results.html.
CEL-SCI Corporation is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company is focused on activating the immune system to fight cancer and infectious diseases. It operates through the segment of research and development of certain drugs and vaccines.
Receive News & Ratings for CEL-SCI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CEL-SCI and related companies with MarketBeat.com's FREE daily email newsletter.